FDA approves Cobenfy: A breakthrough Schizophrenia treatment after decades – Times of India
FDA approves Cobenfy (Picture credit: Reuters/Bristol Myers Squibb) The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s new oral medicine, Cobenfy, for the treatment of schizophrenia in…